SESSION NAME

TIME

Breakfast

I. THE BASICS

8:00 – 8:45

1.   Introduction and Welcome

9:00-9:10

*Merel Nissenberg, Esq.

2. Prostate Cancer in 2022:

9:10-9:35

*Vincent Laudone, MD

              Memorial Sloan Kettering, New York             

3. Prostate Cancer Genetics

9:35-10:00

*Jacob Berchuck, MD

Predictive Genetic Testing and

Dana Farber Cancer Institute

Testing after Diagnosis

Harvard Medical School, Boston

4. Pathology: Aggressive Variant

10:20-10:40

*Jonathan Epstein, MD

Prostate Cancer &/or

Treatment-Associated Small Cell

Neuroendocrine Prostate Cancer

Johns Hopkins, Baltimore

5. Androgen Deprivation Therapy

10:40-11:10

*Mark Markowski, MD

and Novel Anti-Androgens

Johns Hopkins, Baltimore

MORNING BREAK

II. LOCALIZED PROSTATE CANCER

11:10-11:15

6. Active Surveillance, Surgery

11:15-11:45

*Vincent Laudone, MD

Memorial Sloan Kettering

7. Radiation, Focal Therapy

11:45-12:15

         *Daniel Spratt, MD,                 

Case Comprehensive Cancer Center

*Daniel Song, MD

Johns Hopkins, Baltimore

   Q&A

12:00-12:15

All

LUNCH  

III. PSA RECURRENT DISEASE

12:15-1:00

8. PSMA PET and Functional Imaging

1:15-1:35

*Thomas Hope, MD UCSF, San Francisco

9. PSA Persistence

1:35-1:55

*Daniel Spratt, M.D

and Recurrence: Salvage Therapy

Case Comprehensive Cancer Center

10. Oligometastatic Disease:

1:55-2:15

*Daniel Song, MD

Metastasis-Directed Therapy and SBRT

Johns Hopkins, Baltimore

   Q&A

IV. ADVANCED PROSTATE CANCER

2:15-2:30

All

11. Treatment Options and

2:30-3:10

*Mark Markowski, MD

Treatment Sequencing:

*Andrew Armstrong, MD

BAT and Other New Combinations

Duke Medical Center, Durham, NC

   Q&A

3:10-3:30

All

V. PRECISION MEDICINE IN PROSTATE CANCER

12. PSMA Expression on Circulating                                  3:30-3:50

*Andrew Armstrong, MD

Tumor Cells and the PROpel data;

PROPHECY Trial; HRR Mutations

Duke Medical Center, Durham, NC

   Q&A                                                                                     3:50-4:00

VI. IMMUNO-ONCOLOGY IN PROSTATE CANCER

All

13. Car-T Cell Therapy and Bi-Specifics                             4:00-4:20

*Vivek Narayan, MD, MS University of Pennsylvania

14. Vaccine Strategies and                                                  4:20-4:40

*James L. Gulley, MD, PhD

Checkpoint Inhibitors

National Institutes of Health                   

   Q&A                                                                                     4:40-5:00

All

Breakfast                                                                                8:00-8:45

IV. OTHER CONSIDERATIONS and FUTURE DIRECTIONS

15. General Primer on Genomics

8:45-9:00

*Chris Bland,

Pfizer, US Medical Affairs

16. Somatic Testing in Prostate Cancer

9:00-9:20

*Jacob Berchuck, MD

   Q&A

9:20-9:30

All

17. New Directions in Radiotherapy

9:30-9:55

*Michael Zelefsky, MD

Revolutionizing the Treatment of Prostate Cancer

Memorial Sloan Kettering, NY

18. A Validated Prostate Cancer Map

9:55-10:10

*Alan Priester, PhD

to Aid In Focal Treatment Planning

Avenda Health

   Q&A

10:10-10:25

All

19. PROMISE Registry

10:25-10:40

*Kathy Wiedemer

Steering Committee,

PROMISE Registry

BREAK

11:10-11:15

20. “My Prostate Cancer Journey”

10:50-11:10

*Paul Williams             

   Discussion

11:10-11:20

*Clarence Williamson,

*David Sauls

ELECTIONS for 2023 Board

11:20-11:45

Jan Marfyak,   Secretary

21. Panel on Survivorship:

11:45-12:15

*Michael Zaragoza, MD

ED and Emotional Distress Issues

*Paul Williams, *Tony Minter,

*David Sauls

LUNCH

12:15-1:00

22. Report from the

1:00-1:10

*Thomas Kirk, Chair

STEERING COMMITTEE

23. A NEW 5-YEAR STRATEGIC PLAN

1:10-1:45

*LaTanya Patton, Merel Nissenberg

24. Attendees’ General Discussion

1:45-2:00

*All Attendees  

25. Calendaring and Wrap-Up

2:00-2:15

*Merel Nissenberg